TRPV1 and bone cancer: When intrathecally administrated, a powerful TRPV1 agonist resiniferatoxin (RTX, a component contained in the dried latex of the cactus-like plant; [68]) produced a prolonged antinociceptive response in dogs with bone cancer [69], possibly owing to a desensitization of TRPV1 channel.